{
  "insp_id": "239141455400236",
  "layout": "a",
  "customer_id": "1467",
  "customer_name": "Tulane University",
  "customer_addr": "1440 Canal St., Suite 2400 #8401\nNew Orleans, LA 70112",
  "certificate": "72-R-0002",
  "site_id": "001",
  "site_name": "TULANE UNIVERSITY",
  "insp_type": "ROUTINE INSPECTION",
  "date": "27-AUG-2014",
  "report_date": "27-AUG-2014",
  "citations": [
    {
      "code": "2.31(c)(7)",
      "kind": "",
      "repeat": false,
      "desc": "INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).",
      "narrative": "Inspectors reviewed Proposals #4347 and #4356. Both proposals state that, (cid:28)\"Postoperatively the animals will\nreceive one dose of Buprinorphine (0.03 mg/kg IM/SQ), and then as needed for pain.(cid:29)\" Both proposals also state\nthat, \"(cid:28)Topical lidocaine eye drops (0.5%) or proparicaine eye drops (0.5%) will be used to prevent any further\ndiscomfort.(cid:29)\" Finally, both proposals state that, (cid:28)\"All rabbits will be treated for one week with topical Tobradex\nointment twice a day and Vigamox four times a day, to prevent infection.(cid:29)\" When inspectors reviewed 8 animal\nprocedure/usage records pertaining to the aforementioned proposals, none of the records indicate that these\nmedications were administered as outlined in the proposal.\nThe IACUC must review and approve significant changes in proposals and ensure that the activities are conducted\nas stated in the approved proposal. This approval is required in order to ensure that all activities involving animals\nare conducted in compliance with the Animal Welfare Act regulations, and in order to protect the health and\nwell-being of the animals at the facility. The IACUC must ensure that significant changes to approved proposals are\nreviewed and approved prior to implementation.\n***\nTo be corrected by 6 October 2014\nInspection and exit briefing were conducted with facility representatives.\nAdditional Inspectors\nTomlinson Simone, Veterinary Medical Officer"
    }
  ],
  "narrative": "2.31(c)(7)\nINSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC).\nInspectors reviewed Proposals #4347 and #4356. Both proposals state that, (cid:28)\"Postoperatively the animals will\nreceive one dose of Buprinorphine (0.03 mg/kg IM/SQ), and then as needed for pain.(cid:29)\" Both proposals also state\nthat, \"(cid:28)Topical lidocaine eye drops (0.5%) or proparicaine eye drops (0.5%) will be used to prevent any further\ndiscomfort.(cid:29)\" Finally, both proposals state that, (cid:28)\"All rabbits will be treated for one week with topical Tobradex\nointment twice a day and Vigamox four times a day, to prevent infection.(cid:29)\" When inspectors reviewed 8 animal\nprocedure/usage records pertaining to the aforementioned proposals, none of the records indicate that these\nmedications were administered as outlined in the proposal. \nThe IACUC must review and approve significant changes in proposals and ensure that the activities are conducted\nas stated in the approved proposal. This approval is required in order to ensure that all activities involving animals\nare conducted in compliance with the Animal Welfare Act regulations, and in order to protect the health and\nwell-being of the animals at the facility. The IACUC must ensure that significant changes to approved proposals are\nreviewed and approved prior to implementation.\n***\nTo be corrected by 6 October 2014\nInspection and exit briefing were conducted with facility representatives.\nAdditional Inspectors\nTomlinson Simone, Veterinary Medical Officer",
  "animals_total": 17,
  "species": [
    {
      "count": 17,
      "scientific": "Oryctolagus cuniculus",
      "common": "EUROPEAN RABBIT"
    }
  ]
}